In-vitro and In-vivo Antileishmanial Activity of a Compound Derived of Platinum, Oxaliplatin, against Leishmania Major

This study aimed to evaluate the antileishmanial efficacy of oxaliplatin against Leishmania major (L. major) both in-vitro and in-vivo. The IC(50), CC(50), and SI of oxaliplatin against promastigotes, murine macrophages, Raw 264.7 cells, and intramacrophage amastigotes of L. major were investigated...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Iran J Pharm Res
Autors principals: Ghasemi, Ezatollah, Ghaffarifar, Fatemeh, Dalimi, Abdolhossein, Sadraei, Javid
Format: Artigo
Idioma:Inglês
Publicat: Shaheed Beheshti University of Medical Sciences 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059061/
https://ncbi.nlm.nih.gov/pubmed/32184867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22037/ijpr.2019.15364.13046
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars